Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

TLV:REKA Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2.93	7.03	19.31	20.21	18.6	36.89
Short-Term Investments	0.04	-	-	-	-	-
Trading Asset Securities	-	0.04	0.04	0.08	0.04	0.04
Cash & Short-Term Investments	2.97	7.07	19.35	20.29	18.64	36.93
Cash Growth	-45.53%	-63.48%	-4.63%	8.83%	-49.53%	44.22%
Accounts Receivable	111.45	127.11	117.68	120.71	107.37	87.63
Other Receivables	7.83	8.55	8.67	6.83	2.25	1.98
Receivables	119.29	135.66	126.35	127.54	109.62	89.61
Inventory	94.32	82.48	96.6	92.2	89.61	97.85
Prepaid Expenses	-	2.63	1.94	1.83	1.42	0.71
Other Current Assets	-	1.22	7.09	1.28	2.37	2.25
Total Current Assets	216.57	229.05	251.33	243.14	221.66	227.35
Property, Plant & Equipment	134.2	140.07	154.62	163.21	177	181.82
Long-Term Investments	1.28	1.18	1.17	-	-	1.84
Goodwill	35.14	35.14	35.14	15.18	-	-
Other Intangible Assets	23.03	25.7	31.66	20.67	32.97	4.18
Long-Term Deferred Tax Assets	12.13	16.07	10.79	6.22	5.46	4.5
Other Long-Term Assets	-	-	0.01	0.01	0.01	0.01
Total Assets	422.36	447.22	484.72	448.42	437.09	419.69
Accounts Payable	82	87.52	78.89	81.21	57.44	59.89
Accrued Expenses	-	20.98	23.95	17.05	13.61	12.96
Short-Term Debt	26.77	14.35	3.12	-	0.01	5
Current Portion of Long-Term Debt	-	15.2	24.8	30.9	18.96	22.06
Current Portion of Leases	7.13	7.29	6.9	5.59	5.03	4.82
Current Income Taxes Payable	0.33	0.35	1.56	0.76	0.26	0.96
Current Unearned Revenue	-	0.24	0.13	0.1	0.25	0.88
Other Current Liabilities	21.47	12.13	4.45	3.44	3.04	1.7
Total Current Liabilities	137.7	158.04	143.79	139.03	98.61	108.26
Long-Term Debt	66.12	63.62	110.09	91.66	101.23	90.86
Long-Term Leases	34.34	33.7	38.76	37.55	40.6	43.6
Long-Term Deferred Tax Liabilities	1.67	5.27	6.03	2.75	3.16	-
Other Long-Term Liabilities	15.56	14.02	20.74	6.49	11.21	2
Total Liabilities	266.78	285.24	329.14	286.34	264.03	254.1
Common Stock	13.64	13.64	13.64	13.64	13.64	13.64
Additional Paid-In Capital	126.61	126.61	126.61	126.61	126.61	126.61
Retained Earnings	14.75	21.19	14.67	21.35	32.73	25.69
Treasury Stock	-0.51	-0.51	-0.51	-0.51	-0.51	-0.51
Comprehensive Income & Other	1.02	0.99	1.12	0.93	0.54	0.09
Total Common Equity	155.53	161.93	155.54	162.03	173.01	165.53
Minority Interest	0.05	0.05	0.05	0.05	0.05	0.06
Shareholders' Equity	155.57	161.98	155.59	162.08	173.07	165.59
Total Liabilities & Equity	422.36	447.22	484.72	448.42	437.09	419.69
Total Debt	134.36	134.16	183.66	165.7	165.82	166.34
Net Cash (Debt)	-131.39	-127.09	-164.31	-145.41	-147.18	-129.41
Net Cash Per Share	-11.43	-11.13	-14.39	-12.74	-12.89	-11.34
Filing Date Shares Outstanding	11.25	11.41	11.41	11.41	11.41	11.41
Total Common Shares Outstanding	11.25	11.41	11.41	11.41	11.41	11.41
Working Capital	78.87	71.01	107.54	104.11	123.05	119.09
Book Value Per Share	13.82	14.19	13.63	14.19	15.16	14.50
Tangible Book Value	97.35	101.09	88.73	126.18	140.05	161.35
Tangible Book Value Per Share	8.65	8.86	7.77	11.05	12.27	14.14
Land	-	1.89	1.89	2.07	2.07	2.07
Buildings	-	119.29	117.94	124.71	122.66	119.21
Machinery	-	125.12	121.03	112.99	109.84	106.6
Leasehold Improvements	-	63.16	61.15	58.28	57.23	54.74

Source: S&P Global Market Intelligence. Standard template. Financial Sources.